Correlation between Circulating miR-16, miR-29a, miR-144 and miR-150, and the Radiotherapy Response and Survival of Non-Small-Cell Lung Cancer Patients

Int J Mol Sci. 2023 Aug 16;24(16):12835. doi: 10.3390/ijms241612835.

Abstract

Despite the success of current therapy concepts, patients with advanced non-small-cell lung cancer (NSCLC) still have a very poor prognosis. Therefore, biological markers are urgently needed, which allow the assessment of prognosis, or prediction of the success of therapy or resistance in this disease. Circulating microRNAs (miRs) have potential as biomarkers for the prognosis and prediction of response to therapy in cancer patients. Based on recent evidence that circulating miR-16, miR-29a, miR-144 and miR-150 can be regulated by ionizing radiation, the concentration of these four miRs was assessed in the plasma of NSCLC patients at different time points of radiotherapy by digital droplet PCR (ddPCR). Furthermore, their impact on patients' prognosis was evaluated. The mean plasma levels of miR-16, miR-29a, miR-144 and miR-150 significantly differed intra- and inter-individually, and during therapy in NSCLC patients, but showed a strong positive correlation. The individual plasma levels of miR-16, miR-29a and miR-144 had prognostic value in NSCLC patients during or at the end of radiotherapy in Cox's regression models. NSCLC patients with low levels of these three miRs at the end of radiotherapy had the worst prognosis. However, miR-150 plasma levels and treatment-dependent changes were not predictive. In conclusion, circulating miR-16, miR-29a and miR-144, but not miR-150, have a prognostic value in NSCLC patients undergoing radiotherapy.

Keywords: circulating microRNAs; digital droplet PCR; non-small-cell lung cancer; prognosis; radiotherapy.

MeSH terms

  • Carcinoma, Non-Small-Cell Lung* / genetics
  • Carcinoma, Non-Small-Cell Lung* / radiotherapy
  • Circulating MicroRNA* / genetics
  • Humans
  • Lung Neoplasms* / genetics
  • Lung Neoplasms* / radiotherapy
  • MicroRNAs* / genetics
  • Radiation Oncology*

Substances

  • MicroRNAs
  • Circulating MicroRNA
  • MIRN144 microRNA, human
  • MIRN150 microRNA, human
  • MIRN16 microRNA, human

Grants and funding

We would like to thank the Martin Luther University Halle-Wittenberg for the financial support provided by the Open Access Publication Fund.